The long-term safety data for retatrutide is currently limited, but a full list of side effects will be made available once the medication has completed testing and been approved
In addition, recent studies suggest that GLP-1s may be linked with a rare yet serious condition called nonarteritic anterior ischemic optic neuropathy (NAION)
In a field with Lilly and Novo as the Goliaths, a third entrant does not win on another percentage point of weight loss
Patient education : Comprehensive training on injection technique, recognition of hypoglycaemia (when used with other glucose-lowering medications), and sick day rules
If too much semaglutide is taken, it is important to consult with your healthcare provider to seek medical advice
More recently, orally active small-molecule GLP-1R agonists have emerged as an alternative to injectable peptide drugs